When qualifying aesthetic products are dispensed by a registered pharmacy against a valid prescription for a named patient, the supply can be zero-rated for VAT where HMRC's statutory conditions are met.
For practitioners, the practical distinction is between patient-specific prescription supply and ordinary clinic stock. A prescription route creates a named-patient dispensing process through the pharmacy; clinic stock is a separate supply route and does not simply become zero-rated because it is later used on a patient.
When is a pharmacy-dispensed prescription zero-rated?
HMRC VAT Notice 701/57 provides for zero-rating of qualifying goods dispensed to an individual for that individual's personal use, by a registered pharmacist, on the prescription of an appropriate practitioner, where the relevant conditions are satisfied.
For Longeva Pharma, that means qualifying named-patient prescription supplies are treated through the pharmacy dispensing route rather than as ordinary wholesale clinic stock.
Named-patient supply versus clinic stock
A named-patient supply is linked to an identified patient, an appropriate prescription and a dispensing record. Clinic stock is stock held by a practitioner or clinic for general future use and is supplied through a different route.
The distinction matters for VAT, governance, traceability and audit. The pharmacy needs to be able to demonstrate that a prescription supply is genuinely patient-specific rather than clinic stock presented as a named-patient order.
What quantities are acceptable?
Longeva Pharma applies professional and operational controls to named-patient quantities. For dermal filler, we may accept prescriptions for up to 10ml per named patient, subject to the product, proposed treatment, prescription and pharmacist review.
The 10ml figure is a Longeva Pharma governance limit. It is not a statutory UK maximum and it is not itself a VAT threshold. It is an internal safeguard designed to help distinguish a credible patient-specific supply from general clinic stock.
Why use a pharmacy for prescription aesthetic products?
Ordering through a registered pharmacy creates a clearer patient-specific medicines and product-supply process than buying ordinary clinic stock from a general aesthetic wholesaler.
- Zero-rated qualifying prescription supply: where HMRC's conditions are met, qualifying goods dispensed on prescription can be supplied at 0% VAT.
- Pharmacist review: prescriptions and relevant supplies can be reviewed before dispensing.
- Patient-specific audit trail: the supply is linked to the named patient and prescription.
- Traceability: batch, expiry and dispensing records support accountability.
- Prescription queries: unclear, incomplete or inappropriate prescriptions can be referred back before supply.
- Regulatory accountability: a GPhC-registered pharmacy operates within a defined professional framework.
What about dermal fillers?
Dermal fillers can be supplied on a patient-specific prescription route where appropriate. Where the product is a qualifying good and the statutory conditions for pharmacy dispensing are met, the supply can be zero-rated.
For Longeva Pharma, named-patient filler prescriptions remain subject to quantity and pharmacist review. A prescription for up to 10ml may be acceptable where it is credible for the patient's planned treatment; the pharmacy may query or decline an order where the quantity or intended use does not appear consistent with a genuine patient-specific supply.
What is acceptable use?
The prescription route should be used for a genuine named patient. It should not be used simply to convert general clinic stock into a zero-rated purchase. The prescription, quantity, product and intended use need to make sense together and be capable of standing up to pharmacy and VAT scrutiny.
That is why Longeva Pharma may apply additional checks where order patterns or quantities indicate that a supply could in substance be clinic stock rather than patient-specific dispensing.
The commercial benefit for practitioners
Where the conditions for zero-rating are met, the VAT difference can be material to the cost of a patient-specific aesthetic order. At the same time, the pharmacy route provides a stronger dispensing record, clearer provenance and professional oversight.
This is one of the key differences between obtaining a genuine named-patient supply through a registered pharmacy and simply purchasing stock through an aesthetic wholesaler.
Browse our botulinum toxins and diluents, read our guide to common aesthetic prescription errors, or see who can prescribe botulinum toxin in the UK.
Key takeaways
- Qualifying products dispensed by a registered pharmacy against a valid named-patient prescription can be zero-rated where HMRC's conditions are met.
- Patient-specific prescription supply is different from ordinary clinic stock.
- Longeva Pharma may accept up to 10ml of filler per named patient, subject to pharmacist review.
- The 10ml limit is an internal governance control, not a statutory or VAT threshold.
- The prescription route must reflect genuine patient-specific use rather than general stock purchasing.
- Using a registered pharmacy adds dispensing records, traceability and pharmacist oversight.
This article is general information for UK healthcare and aesthetic professionals. VAT treatment depends on the facts of the supply and current HMRC rules.